Conflict of interest statement: There are no conflicts of interest.182. South Asian J Cancer. 2018 Apr-Jun;7(2):118-122. doi: 10.4103/sajc.sajc_116_18.Practical consensus recommendations on Her2 +ve breast cancer with solitary brainmets.Rohatgi N(1), Munshi A(2), Bajpai P(3), Singh M(4), Sahai S(2), Ahmad M(5), SinghK(6), Singh H(7), Parikh PM(8), Aggarwal S(9).Author information: (1)Department of Medical Oncology, Max Hospital, New Delhi, India.(2)Department of Radiation Oncology, Fortis Hospital, Gurugram, Haryana, India.(3)Department of Medical Oncology, Manipal Super Specialty Hospital, New Delhi,India.(4)Department of Medical Oncology, Mahavir Cancer Sansthan, Patna, Bihar, India.(5)Department of Radiation Oncology, Jolly Grant Himalayan Institute, Dehradoon, Uttarakhand, India.(6)Department of Radiation Oncology, MAMS, New Delhi, India.(7)Department of Radiaton Oncology, Action Balajee Cancer Center, New Delhi,India.(8)Department of Oncology, Shalby Cancer and Research Institute, Mumbai,Maharashtra, India.(9)Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.Breast cancer is a common cause of brain metastases, with metastases occurring inat least 10-16% of patients. Longer survival of patients with metastatic breastcancer and the use of better imaging techniques are associated with an increased incidence of brain metastases. Current therapies include surgery, whole-brainradiation therapy, stereotactic radiosurgery, chemotherapy and targetedtherapies. However, the timing and appropriate use of these therapies iscontroversial and careful patient selection by using available prognostic toolsis extremely important. Expert oncologist discussed on the mode of treatment toextend the OS and improve the quality of life ofHER2-positivebreast cancerpatients with Solitary brain metastases. This expert group used data frompublished literature, practical experience and opinion of a large group ofacademic oncologists to arrive at this practical consensus recommendations forthe benefit of community oncologists.DOI: 10.4103/sajc.sajc_116_18 PMCID: PMC5909288PMID: 29721477 